Literature DB >> 19681189

South Africa tries new approach to resistant tuberculosis.

Clare Kapp.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19681189     DOI： 10.1016/s0140-6736(09)61437-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  1 in total

1.  Suitability of Xpert MTB/RIF and genotype MTBDRplus for patient selection for a tuberculosis clinical trial.

Authors:  Sven O Friedrich; Amour Venter; Xavier A Kayigire; Rodney Dawson; Peter R Donald; Andreas H Diacon
Journal:  J Clin Microbiol       Date:  2011-06-08       Impact factor: 5.948
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.